Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

Importance Tracheal intubation is one of the most commonly performed and high-risk
interventions in critically ill patients. Limited information is available on adverse peri-intubation …

Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Rationale: Noninvasive ventilation (NIV) is increasingly used in patients with acute respiratory
distress syndrome (ARDS). The evidence supporting NIV use in patients with ARDS …

In this narrative review, we discuss the relevant issues of therapeutic plasma exchange (TPE)
in critically ill patients. For many conditions, the optimal indication, device type, frequency, …

Background In immunocompromised patients with acute hypoxemic respiratory failure (ARF),
initial management aims primarily to avoid invasive mechanical ventilation (IMV). Methods …

Over the coming years, accelerating progress against cancer will be associated with an
increased number of patients who require life-sustaining therapies for infectious or toxic …

Objective To assess the efficacy and safety of lenzilumab in patients with severe coronavirus
disease 2019 (COVID-19) pneumonia. Methods Hospitalized patients with COVID-19 …

Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution
to guide clinical decision-making. Here, we use deep neural networks over an institution…